Remember to take the opportunity to influence the future direction of IDSA and HIVMA by participating in the board elections.

Exciting changes are on the horizon with the IDSA Board of Directors’ recent approval of recommendations from the Governance Task Force.

IDSA and the American Society for Microbiology (ASM) have published an updated “Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases” in Clinical Infectious Diseases. 

In a recent joint statement, the leaders of IDSA, HIVMA, SHEA and PIDS warned of the consequences to individual and public health of continuing “zero-tolerance” border policies and of large scale detention of thousands of weakened and vulnerable individuals.

U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, announced that FDA is working with the Centers for Medicare and Medicaid Services (CMS) to develop new payment models for urgently needed new antibiotics that would help stimulate research and development as well as promote judicious use.

In a letter to U.S. Ambassador to the United Nations Nikki Haley, IDSA urged the U.S. U.N. mission to push for strong targets on detecting, preventing and treating tuberculosis.

Fifteen medical students from across the U.S. have been selected by HIVMA and the IDSA Foundation to receive funding for clinical learning and research projects through the HIVMA Medical Students Program.

Join IDSA and the National Institute for Allergy and Infectious Diseases (NIAID) for an IDWeek premeeting workshop on research training programs, career development, and grant writing strategies for ID physician-scientists on Tuesday, Oct. 2 from 1:00-5: 00 PM PDT.

The Agency for Healthcare Research and Quality (AHRQ) is seeking nominations for seven new members of its National Advisory Council.

Advocating for the ID and HIV policies that matter to you is vital.